A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors
- 24 May 1995
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 278 (3) , 265-269
- https://doi.org/10.1016/0014-2999(95)00173-i
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inhibition of rat colon contractility by prostacyclin (IP‐) receptor agonists: involvement of NANC neurotransmissionBritish Journal of Pharmacology, 1995
- Characterization of prostanoid receptors on rat neutrophilsBritish Journal of Pharmacology, 1994
- 2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): A new, structurally-novel prostacyclin partial agonist: 1) inhibition of platelet aggregation and mechanism of actionThrombosis Research, 1994
- Non-prostanoid prostacyclin mimeticsDrugs of the Future, 1994
- Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acidJournal of Medicinal Chemistry, 1993
- Primate vascular responses to octimibate, a non‐prostanoid agonist at the prostacyclin receptorBritish Journal of Pharmacology, 1991
- Octimibate, a potent non‐prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptorBritish Journal of Pharmacology, 1991
- Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptorsBritish Journal of Pharmacology, 1989
- Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimeticsBritish Journal of Pharmacology, 1986